A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: poisonous (3), deadly (1), lethal (5), noxious (2), contaminated (25)

Doctor urges parents to avoid over-the-counter cough medicines for children

Description
A Southampton doctor has urged parents to avoid using over-the-counter cough syrups and medicines to treat coughs and colds
Url
/AboutTheTrust/Newsandpublications/Latestnews/2017/December-2017/Doctor-urges-parents-to-avoid-over-the-counter-cough-medicines-for-children.aspx

DH IVIg approved indications summary_May 2012

Description
Demand Management Poster Red Priority - High Short Term Long Term Blue Priority - Medium Short Term Grey Priority - Low Long Term Black Condition Alloimmune thrombocytopenia (foeto-maternal
Url
/Media/SUHTExtranet/TrustMedicinesFormulary/Forms/DH-IVIg-approved-indications-Summary-Poster-Feb-2106.pdf

Ig request form 0 advice for users

Description
Immunoglobulin Requesting Advice FormIntroduction The provision of Immunoglobulin was adopted as a Specialist Commissioning Service by the NHS Commissioning Board in April 2012. The process builds upon
Url
/Media/SUHTExtranet/TrustMedicinesFormulary/Forms/Ig-Request-Form-0-Advice-for-users.pdf

DH IVIg approved indications full guidance July 2011

Description
DH INFORMATION READER BOX Policy HR / Workforce Management Planning / Clinical Performance Document Purpose Gateway Reference Title Author Publication Date Target Audience Estates Commi
Url
/Media/SUHTExtranet/TrustMedicinesFormulary/Forms/DH-IVIg-approved-indications-Full-Guidance-July-2011.pdf

Enfortumab-Vedotin-Pembrolizumab

Description
Chemotherapy Protocol UROTHELIAL CANCER Enfortumab vedotin-Pembrolizumab (EV-P) Regimen • Urothelial – Enfortumab vedotin - Pembrolizumab Indication • First-line treatment of adult patients with
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Enfortumab-Vedotin-Pembrolizumab.pdf

Bendamustine

Description
Chemotherapy Protocol LYMPHOMA BENDAMUSTINE There are multiple versions of this protocol in use. Please ensure you have the correc
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine.pdf

Atezolizumab (1875mg 21-days) SC

Description
Chemotherapy Protocol UROTHELIAL CANCER Atezolizumab SC (1875mg – 21 days) Regimen • Urothelial cancer – Atezolizumab monotherapy (1st or 2nd line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab-SC-1875mg-21-days.pdf

Bendamustine-Rituximab

Description
Chemotherapy Protocol LYMPHOMA BENDAMUSTINE-RITUXIMAB There are multiple versions of this protocol in use. Please ensure you have the correct protoco
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine-Rituximab.pdf

Bendamustine_90_RituximabSplit

Description
Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (90)-RITUXIMAB (Split) There are multiple versions of this protocol in use that vary
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-90-RituximabSplit.pdf

Bendamustine_90_Rituximab

Description
Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (90)-RITUXIMAB There are multiple versions of this protocol in use that vary dependi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-90-Rituximab.pdf
1 to 10 of 82
Previous 1 2 3 4 5 … Next